Phase I Study of BMS-690514 in Japanese Patients With Solid Tumors
NCT00516451
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
9
Enrollment
INDUSTRY
Sponsor class
Conditions
Cancer
Interventions
DRUG:
BMS-690514
Sponsor
Bristol-Myers Squibb